RxDoctor Payments Data

Ellis Tinsley, MD

Surgery · Wilmington, NCNPI 1285614578

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $47,753 of the $56,016 with a category attached, or 85.2%. Johnson & Johnson accounts for 92.9% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $39,378 and has fallen 97.6% since, to $959 in 2025. Among surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,016in general payments, 2019–2025

Across 159 payments — averaging $352.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$52K
  • Medtronic$2K
  • Bard Peripheral Vascular, Inc.$735
  • W. L. Gore & Associates, Inc.$287
  • Venclose Inc.$280
  • Organogenesis Inc.$248
  • plus $881 from 20 others

What the payments were for

  • Consulting fees$3001%
  • Speaking & faculty fees$47,75385%
  • Travel & lodging$2,7995%
  • Food & beverage$5,1159%
  • Education$500%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,016 in reported general payments places this provider in the 95th percentile of 970 surgery providers in North Carolina.

See all surgery providers in North Carolina →

Medicare billing

Part B allowed, 2024
$1,270,211
Medicare patients
1,391
Services billed
8,562

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol33$430
ClopidogrelClopidogrel Bisulfate21$258

Paid to pharmacies, not to this prescriber.

Other surgery in Wilmington

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →